Gastrointestinal effects of nonsteroidal anti-inflammatory therapy (Q33676713)

28 July 2017

1 reference

title

Gastrointestinal effects of nonsteroidal anti-inflammatory therapy (English)

1 reference

28 July 2017

Raskin JB

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

American Journal of Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

106

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

3S-12S

1 reference

Mechanism of action of nonsteroidal anti-inflammatory drugs

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Epidemiological and financial aspects of the use of non-steroidal anti-inflammatory analgesics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Prevalence and characteristics of multiple analgesic drug use in an elderly study group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Analgesic drug use in an ambulatory elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Adverse drug reactions and the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

NSAIDs and risk of upper gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Non-steroidal anti-inflammatory drugs and peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Survival, prognosis, and causes of death in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Gastric adaptation. Studies in humans during continuous aspirin administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Peptic ulcer in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Non-aspirin nonsteroidal anti-inflammatory drugs and active gastroduodenal ulceration in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Prostanoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Effect of indomethacin on basal and histamine stimulated human gastric acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900112-6

10.1016/S0002-9343(99)00112-6

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference